|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 26 of 41 found articles
| Title: |
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness |
| Author: |
Czuczman, M.S. Leonard, J.P. Jung, S. Johnson, J.L. Hsi, E.D. Byrd, J.C. Cheson, B.D. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 23 () nr. 9 pages 2356-2362 |
| Year: |
2012 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 26 of 41 found articles
| << previous | next >> |